| Quest – Discovery Stage Research Projects | University of California, Berkeley | Scalable, Defined Production of Oligodendrocyte Precursor Cells to Treat Neural Disease and Injury |
$1,627,099 |
| Tools and Technologies III | University of California, Berkeley | Engineered Biomaterials for Scalable Manufacturing and High Viability Implantation of hPSC-Derived Cells to Treat Neurodegenerative Disease |
$1,239,276 |
| Tools and Technologies II | University of California, Berkeley | Engineering Defined and Scaleable Systems for Dopaminergic Neuron Differentiation of hPSCs |
$1,340,816 |
| Tools and Technologies I | University of California, Berkeley | Directed Evolution of Novel AAV Variants for Enhanced Gene Targeting in Pluripotent Human Stem Cells and Investigation of Dopaminergic Neuron Differentiation |
$918,000 |
| Shared Labs | University of California, Berkeley | The Berkeley Human Embryonic Stem Cell Shared Research Laboratory |
$1,227,659 |
| Shared Labs | University of California, Berkeley | The Berkeley Human Embryonic Stem Cell Shared Research Laboratory |
$1,673,221 |
